Ijeoma F. Uchegbu University of London

University of London LogoIjeoma F. Uchegbu University of London

Ijeoma is the founding Chief Scientific Officer (CSO) of Nanomerics. In addition, Ijeoma holds a chair in Pharmaceutical Nanosciences at University College London.

Ijeoma obtained her PhD from the School of Pharmacy, University of London, before moving to a lectureship in the Department of Pharmaceutical Sciences, University of Strathclyde, eventually being appointed to a Chair in Drug Delivery at the same university.  At the University of Strathclyde Uchegbu worked on the self-assembly of polymers, creating new polymers capable of forming high stability nanosystems and functional nanomedicines.

An appointment to a chair in Pharmaceutical Nanoscience at the School of Pharmacy, University of London followed, just prior to the launch of Nanomerics.  Ijeoma has received a number of awards, notably the UK’s Women of Outstanding Achievement Award (2007) in Science Engineering and Technology (http://www.ukrc4setwomen.org/) awarded by the former Department and Trade and Industry’s (now Department of Business, Innovation and Skills) United Kingdom Resource Centre.

Ijeoma F. Uchegbu University of London

Research interests

  • Polymer amphiphile design and synthesis
  • Polymer self assembly
  • Nanomedicines design and fabrication
  • Nanodiagnostics design and fabrication
  • Delivery of peptides and macromolecules to the brain
  • Oral absorption of drugs

Teaching interests

  • Teaching on the Biopharmaceuticals and Nanomedicine modules

Current collaborations and partnerships

  • Nanomerics Ltd – the development of METDoloron, a pain therapeutic
  • AMT Ltd. – the flow synthesis of polymer amphiphiles
  • Professor Andreas G. Schatzlein (UCL School of Pharmacy) – nanomedicines design, fabrication and testing
  • Dr Julian Moger (Physics, Exeter University) – the mechanistic understanding of Nanomerics MET drug delivery platform
  • Dr Susan Alexander (UCL Surgery and Interventional Sciences) and Professor Robert Brown (UCL Surgery and Interventional Sciences) – the design and fabrication of antibiotic therapeutic entities
  • Dr Marilena Lozouidou (UCL Surgery and Interventional Sciences) – the development of cancer diagnostics
  • Professor Thanh Nguyen (UCL Physics and Astronomy) and AstraZeneca – the development of targeted theranostics